The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Eur Respir J. 2019 Jan 3;53(1):1802089.
doi: 10.1183/13993003.02089-2018.
Print 2019 Jan.
1 Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
2 Amsterdam University Medical Centers, Location Meibergdreef, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
3 Universitaetskinderklinik fuer Kinder- und Jugendmedizin, Ruhr University, Bochum, Germany.
4 Emerging Bacterial Pathogens, IRCCS San Raffaele Scientific Institute, Milan, Italy.
5 Centre for Lung Infection and Immunity, UCT Lung Institute and Dept of Medicine, University of Cape Town, Cape Town, South Africa.
6 University College London, London, UK.
7 Pneumology Dept, Centro Hospitalar Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
8 ISPUP-EP unit, Faculty of Medicine, University of Porto, Porto, Portugal.
9 APHP, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), Bactériologie-Hygiène, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France.
10 Sorbonne Université, Université Pierre et Marie Curie 06, Unité 1135, Team E13 (Bactériologie), CR7 INSERM, Centre d'Immunologie et des Maladies Infectieuses, Paris, France.
11 Riga East University Hospital, and WHO Collaborating Centre, Riga, Latvia.
12 German Center for Infection Research Tuberculosis Unit, Research Center Borstel, Borstel, Germany.
13 Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
14 Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
15 The Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.